165 related articles for article (PubMed ID: 22093033)
21. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
[TBL] [Abstract][Full Text] [Related]
22. Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis?
Ni JD; Xiong YZ; Wang XJ; Xiu LC
Int J STD AIDS; 2013 Feb; 24(2):117-22. PubMed ID: 23467291
[TBL] [Abstract][Full Text] [Related]
23. Circulating Interferon-
Grzegorzewska AE; Świderska MK; Mostowska A; Jagodziński PP
Biomed Res Int; 2017; 2017():3713025. PubMed ID: 29226133
[TBL] [Abstract][Full Text] [Related]
24. Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta-analysis.
Liu J; Wu H; Chen H
Hepatol Res; 2018 Feb; 48(2):119-126. PubMed ID: 29197147
[TBL] [Abstract][Full Text] [Related]
25. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.
Peces R; de la Torre M; Alcázar R; Urra JM
Am J Kidney Dis; 1997 Feb; 29(2):239-45. PubMed ID: 9016896
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls.
Froutan-Pishbijari H; Ghofrani H; Mirmomenm S; Kazemi-Asl S; Nassiri-Toosi M; Farahvash MJ; Toroghi HH; Aminian K; Mansour-Ghanaei F; Bagherzadeh AH
Med Sci Monit; 2004 Dec; 10(12):CR679-83. PubMed ID: 15567986
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus infection and related factors in hemodialysis patients in China - systematic review and meta-analysis.
Wang C; Sun J; Zhu B; Larsen S; Yu R; Wu J; Zhao W
Ren Fail; 2010; 32(10):1255-64. PubMed ID: 20954991
[TBL] [Abstract][Full Text] [Related]
29. Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.
Fabrizi F; Martin P; Messa P
Int J Artif Organs; 2015 Dec; 38(12):625-31. PubMed ID: 26821784
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B status in hemodialysis patients.
Guimarães MNC; Facincani T; Santos SSD
Arq Gastroenterol; 2017 Dec; 54(4):356-358. PubMed ID: 28724049
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
32. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients.
Navarro JF; Teruel JL; Mateos M; Ortuño J
Clin Nephrol; 1994 Feb; 41(2):113-6. PubMed ID: 8004827
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy.
Chlabicz S; Grzeszczuk A; Łapiński TW
Med Sci Monit; 2002 May; 8(5):CR379-83. PubMed ID: 12011781
[TBL] [Abstract][Full Text] [Related]
35. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
Chow KM; Law MC; Leung CB; Szeto CC; Li PK
Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center.
Al Saran K; Sabry A; Al Halawany Z; Ismail M
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):185-91. PubMed ID: 24434410
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.
Udomkarnjananun S; Takkavatakarn K; Praditpornsilpa K; Nader C; Eiam-Ong S; Jaber BL; Susantitaphong P
J Nephrol; 2020 Apr; 33(2):343-354. PubMed ID: 31701375
[TBL] [Abstract][Full Text] [Related]
38. Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis.
Kamath GR; Shah DP; Hwang LY
Vaccine; 2014 Apr; 32(20):2265-74. PubMed ID: 24631093
[TBL] [Abstract][Full Text] [Related]
39. [Viral hepatitis infection and response to the hepatitis B vaccine in hemodialyzed patients].
Curciarello JO; Corallini O; Adrover RE; Chiera AO; Giammona AM; Barbero R; Apraiz M; Belloni PO; Neumann M; Jmelnitzky AC
Acta Gastroenterol Latinoam; 1994; 25(5):291-6. PubMed ID: 7785401
[TBL] [Abstract][Full Text] [Related]
40. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
